Semaglutide/Tirzepatide Pen (5mg)

$61.50

1 Unit
$61.5 per unit
$61.50
2 Units
$59.96 per unit (save 3% per unit)
$119.92
$123.00
3 Units
$58.43 per unit (save 5% per unit)
$175.29
$184.50
4 Units
$56.89 per unit (save 7% per unit)
$227.56
$246.00
5 Units
$55.35 per unit (save 10% per unit)
$276.75
$307.50
6 Units
$53.81 per unit (save 13% per unit)
$322.86
$369.00
7 Units
$52.28 per unit (save 15% per unit)
$365.96
$430.50
8 Units
$50.74 per unit (save 17% per unit)
$405.92
$492.00
9 Units
$49.2 per unit (save 20% per unit)
$442.80
$553.50
10 Units
$47.66 per unit (save 23% per unit)
$476.60
$615.00
Category:

Description

Tirzepatide and Semaglutide are peptide therapies that offer significant benefits for managing type 2 diabetes and obesity, with Tirzepatide demonstrating slightly superior efficacy in weight loss and glycemic control due to its dual action on GLP-1 and GIP receptors.
Both medications promote weight loss, improve blood sugar regulation, and reduce cardiovascular risk factors, though Tirzepatide’s dual-receptor mechanism provides enhanced metabolic benefits.

Weight Loss: Tirzepatide has shown greater effectiveness in clinical trials, with some participants achieving up to 20% body weight reduction, compared to Semaglutide’s average of around 15%.
Blood Sugar Control: Tirzepatide demonstrates superior HbA1c reduction compared to Semaglutide, particularly in patients with type 2 diabetes, due to its dual agonist activity.
Cardiovascular Benefits: Both drugs reduce cardiovascular risk factors such as high blood pressure, cholesterol levels, and insulin resistance; Tirzepatide may offer additional advantages due to its enhanced metabolic effects.
Appetite and Craving Suppression: Both medications reduce appetite and food intake by acting on brain regions that regulate hunger, but Tirzepatide’s dual action leads to stronger suppression of cravings.
Additional Benefits: Preliminary research suggests potential benefits in treating fatty liver disease and supporting bone health, with Tirzepatide showing protective renal effects such as reduced albuminuria.
Side Effects: Common side effects include nausea, vomiting, and diarrhea due to slowed gastric emptying; however, Tirzepatide may cause less nausea than Semaglutide due to the GIP component.

Related products